Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma |
Columbia University Medical Center / Darrell Yamashiro, MD, PhD |
Innovation Grants |
2013 |
New York |
Dissecting the Mechanism of Overgrowth and Tumorigenesis in Beckwith-Wiedemann Syndrome |
University of Pennsylvania / Jennifer Kalish, MD, PhD |
Young Investigator Grants |
2013 |
Pennsylvania |
Genomic Alterations in ETV6 Predict Outcome in Pediatric AML |
Fred Hutchinson Cancer Research Center / Heather Helton, MD |
Young Investigator Grants |
2013 |
Washington |
Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers |
Dana-Farber Cancer Institute / Charles Roberts, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Myron Ignatius, PhD |
'A' Award Grants |
2012 |
Massachusetts |
Targeting Neovascularization in Graft-Versus-Host Disease |
Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD |
Innovation Grants |
2012 |
New York |
Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees |
Huntsman Cancer Institute / Lisa Cannon-Albright, PhD |
Innovation Grants |
2012 |
Utah |
V alpha-invariant NKT cells as a novel platform for cancer immunotherapy |
Baylor College of Medicine / Leonid Metelitsa, MD, PhD |
Innovation Grants |
2012 |
Texas |
Developing Immune-modulatory Strategies Against Primary and Metastatic Tumors in the Central Nervous System |
Case Western Reserve University / Alex Huang, MD, PhD |
Innovation Grants |
2012 |
Ohio |
Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL |
The Johns Hopkins University School of Medicine / Donald Small, MD, PhD |
Innovation Grants |
2012 |
Maryland |